Gastrointestinal Cancer News

Delaying surgery appeared associated with worse OS and DFS among patients with locally advanced rectal cancer and poor tumor pathologic response to neoadjuvant chemoradiotherapy, according to study results published in JAMA Surgery.

LAS VEGAS — Multimodal circulating tumor DNA blood-based colorectal cancer screening tests may have clinically meaningful performance among patients in an average risk screening population, according to a presentation.

The Society for Immunotherapy of Cancer announced the inaugural class of Fellows of the Academy of Immuno-Oncology.

Devimistat plus a modified standard-of-care chemotherapy regimen failed to extend OS among patients with metastatic pancreatic cancer, according to results of the randomized phase 3 AVENGER 500 trial released by the agent’s manufacturer.

The economic burden of cancer care in the United States remained heavy for patients, who incurred more than $21 billion in costs in 2019, according to part two of the Annual Report to the Nation on the Status of Cancer.

The addition of durvalumab to standard first-line chemotherapy extended survival among patients with advanced biliary tract cancer, according to topline data released by the agent’s manufacturer.

LAS VEGAS – Prioritizing equity efforts and taking three key steps toward improving accessibility and representation could move the needle on health disparities in colon cancer screening, according to an ACG Postgraduate Course presentation.

This award goes to a product that stands out as a major disruption to the practice of gastroenterology.

This award goes to a woman in the field who has emerged as a leader and as an example to younger women of how a successful career can unfold.

The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests done at home may boost colonoscopy compliance, according to a presentation at the American College of Surgeons Clinical Congress.